Research and Clinical Trials

Mayo Clinic researchers have found that the oral drug apixaban is safe and effective to treat blood clots in patients undergoing cancer therapy. Apixaban was[...]

A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]

Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, talks about her cellular therapy research.

Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]

When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved cognitive function and demonstrated[...]

Rose geranium oil may help ease the symptoms of nasal vestibulitis, according to the results of a small observational study by Mayo Clinic researchers. The[...]

Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor (CAR)-T cell therapy in treating cancer. They presented[...]

Researchers at Mayo Clinic have identified three specific gene types that account for a known twofold to threefold increase in myeloma diagnoses among African-Americans. Researchers[...]

A team of researchers from the Mayo Clinic Cancer Center has been awarded a five-year, $11.5-million Specialized Program of Research Excellence (SPORE) grant in hepatobiliary[...]

Tanios S. Bekaii-Saab, M.D., a medical oncologist at Mayo Clinic in Phoenix/Scottsdale, Arizona, explains how his research interests grew out of a desire to improve treatment options for his patients.